Cargando…

The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design

BACKGROUND: At present, diabetes is a chronic disease of great cost and heavy burdens. The International Diabetes Federation has repeatedly warned that by 2025, the global number of diabetics would rise to 333 million from 194 million in 2003. Although the occurrence of diabetes in developing countr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xiao, Guo, Liping, Shang, Hongcai, Ren, Ming, Wang, Yue, Huo, Da, Lei, Xiang, Wang, Hui, Zhai, Jingbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632405/ https://www.ncbi.nlm.nih.gov/pubmed/26530718 http://dx.doi.org/10.1186/s13063-015-0990-9

Ejemplares similares

JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial
por: Cao, Hongbo, et al.
Publicado: (2010)

JinQi Jiangtang Tablet Regulates Gut Microbiota and Improve Insulin Sensitivity in Type 2 Diabetes Mice
por: Cao, Ying, et al.
Publicado: (2019)

JinqiJiangtang tablets for pre-diabetes: A randomized, double-blind and placebo-controlled clinical trial
por: Wang, Hui, et al.
Publicado: (2017)

The Hypoglycemic Effect of JinQi Jiangtang Tablets Is Partially Dependent on the Palmatine-Induced Activation of the Fibroblast Growth Factor Receptor 1 Signaling Pathway
por: Li, Siming, et al.
Publicado: (2022)

Renoprotective effect of JinQi-JiangTang tablet on high-fat diet and low-dose streptozotocin-induced type 2 diabetic rats
por: Jiang, Bingjie, et al.
Publicado: (2018)

Development and Validation of an UPLC-MS/MS Method for Pharmacokinetic Comparison of Five Alkaloids from JinQi Jiangtang Tablets and Its Monarch Drug Coptidis Rhizoma
por: Sun, Lili, et al.
Publicado: (2017)

Natural Deep Eutectic Solvents for Simultaneous Extraction of Multi-Bioactive Components from Jinqi Jiangtang Preparations
por: Yang, Lele, et al.
Publicado: (2019)

Integrating metabolomic data with machine learning approach for discovery of Q-markers from Jinqi Jiangtang preparation against type 2 diabetes
por: Yang, Lele, et al.
Publicado: (2021)

Observation on clinical effect of Huoxue-Jiangtang decoction formula granules in treating prediabetes: a randomized prospective placebo-controlled double-blind trial protocol
por: Zhang, Peng-Xiang, et al.
Publicado: (2022)

The key role of Shenyan Kangfu tablets, a Chinese patent medicine for diabetic nephropathy: study protocol for a randomized, double-blind and placebo-controlled clinical trial
por: Wang, Hui, et al.
Publicado: (2013)

Study on the mechanism of Jin Gui Shen Qi Pill in the treatment of erectile dysfunction based on bioinformatics analysis
por: Xiang, Jingjing, et al.
Publicado: (2022)

Randomized, double-blind, placebo-controlled phase I dose escalation study of Dan Qi Tong Mai tablet in healthy volunteers
por: Gou, Zhong-ping, et al.
Publicado: (2019)

Studies on Preformulation and Formulation of JIN-001 Liquisolid Tablet with Enhanced Solubility
por: Kim, Han-Sol, et al.
Publicado: (2022)

Randomized, Double-Blinded, Multicenter, Placebo-Controlled Trial of Shenfu Injection for Treatment of Patients with Chronic Heart Failure during the Acute Phase of Symptom Aggravation (Yang and Qi Deficiency Syndrome)
por: Wang, Xianliang, et al.
Publicado: (2019)

Efficacy and safety of Jin-shui Huan-xian granule for idiopathic pulmonary fibrosis: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
por: Yang, Shu-guang, et al.
Publicado: (2022)

Acupuncture for prostatectomy incontinence: study protocol for a multicenter single-blind randomized parallel controlled trial
por: Zhang, Yao, et al.
Publicado: (2022)

Influence of ShuJinHuoXue Tablets on Ischemia Reperfusion Injury of Animals’ Skeletal Muscle
por: Tong, Zhihong, et al.
Publicado: (2012)

Yi Jin Jing
por: Jiménez Martín, Pedro J.‏

Qi-Shen-Yi-Qi Dripping Pills for the Secondary Prevention of Myocardial Infarction: A Randomised Clinical Trial
por: Shang, Hongcai, et al.
Publicado: (2013)

A Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial of Qi-Zhi-Wei-Tong Granules on Postprandial Distress Syndrome-Predominant Functional Dyspepsia
por: Su, Qing, et al.
Publicado: (2018)

The chemical components, action mechanisms, and clinical evidences of YiQiFuMai injection in the treatment of heart failure
por: Lv, Shichao, et al.
Publicado: (2022)

ResNet for recognition of Qi-deficiency constitution and balanced constitution based on voice
por: Lai, Tong, et al.
Publicado: (2022)

Evidence and Potential Mechanisms of Jin-Gui Shen-Qi Wan as a Treatment for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Hu, Zhipeng, et al.
Publicado: (2021)

Jin-Gui-Shen-Qi Wan ameliorates diabetic retinopathy by inhibiting apoptosis of retinal ganglion cells through the Akt/HIF-1α pathway
por: Liang, Dan, et al.
Publicado: (2023)

Design and Methodology of a Multicenter Randomized Clinical Trial to Evaluate the Efficacy of Tongmai Jiangtang Capsules in Type 2 Diabetic Coronary Heart Disease Patients
por: Wang, Yu, et al.
Publicado: (2021)

Corrigendum: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial of Qi-Zhi-Wei-Tong Granules on Postprandial Distress Syndrome-Predominant Functional Dyspepsia
Publicado: (2019)

Light People: Professor Dayong Jin
por: Zhang, Ying
Publicado: (2021)

Jian Pi Li Qi Decoction Alleviated Postembolization Syndrome Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Xu, Litao, et al.
Publicado: (2015)

Bjorken limit and the Jin-Martin lower bound
por: Khalil, M B, et al.
Publicado: (1971)

Ayurvedic polyherbal combination (PDBT) for prediabetes: A randomized double blind placebo controlled study
por: Nakanekar, Amit, et al.
Publicado: (2019)

Efficacy and safety of Xinnaoning capsule in treating chronic stable angina (qi stagnation and blood stasis syndrome): Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
por: Zhao, Jun-Nan, et al.
Publicado: (2019)

Jiangtang Decoction Ameliorates Diabetic Kidney Disease Through the Modulation of the Gut Microbiota
por: Hong, Jinni, et al.
Publicado: (2023)

Exploring the Regulation of Jiangtang Tiaozhi Formula on the Biological Network of Obese T2DM Complicated With Dyslipidemia Based on Clinical Transcriptomics
por: Bao, Tingting, et al.
Publicado: (2022)

Shenqi Jiangtang Granule Ameliorates Kidney Function by Inhibiting Apoptosis in a Diabetic Rat Model
por: Zhang, Qian, et al.
Publicado: (2019)

Effectiveness of Traditional Chinese Medicine Compound JieDuTongLuoShengJin Granules Treatment in Primary Sjögren's Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Li, Ben, et al.
Publicado: (2017)

Verification of the Efficacy and Safety of Qi-Replenishing Chinese Medicine in Treating Prediabetes: A Meta-Analysis and Literature Review
por: Xia, Shujie, et al.
Publicado: (2020)

Efficiency and Safety of Baofei Granules in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial
por: Sun, Yuan, et al.
Publicado: (2022)

Reply to Jin et al. and to Sun et al.
por: Boucly, Athénaïs, et al.
Publicado: (2021)

Efficacy and safety of Qiangli Dingxuan tablet combined with amlodipine besylate for essential hypertension: a randomized, double-blind, placebo-controlled, parallel-group, multicenter trial
por: Lin, Jianguo, et al.
Publicado: (2023)

Efficacy and safety of Suxiao Jiuxin Pill in the treatment of stable angina (Qi stagnation and blood stasis syndrome): study protocol of a randomized, double-blind, placebo-controlled, multi-center clinical trial
por: Ruan, Xiaofen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jhalfuqhmd92lg2uep5gqe5kpt